PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2026The European Journal of Contraception & Reproductive Health Care2 citations

The effects of glucagon-like peptide-1 receptor agonists on fertility, contraception, and pregnancy: clinical perspectives

View Full Paper
BDBerna DilbazÇAÇağlayan Ateş

Abstract

GLP-1 RAs are valuable adjuncts in managing obesity-related infertility, particularly in patients with PCOS. Clinicians must counsel patients regarding contraceptive reliability during treatment, ensure adequate washout before attempting conception, and recognise that while fertility benefits are well documented, pregnancy safety data remain limited.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dilbaz et al. (2026) studied this question.

synapsesocial.com/papers/69bf3924c7b3c90b18b43773https://doi.org/10.1080/13625187.2026.2644895
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Semaglutide and human reproduction: caution at the intersection of energy balance, ovarian function, and follicular development2025 · 5 citations
  2. 2Incidence of GLP ‐1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011–2022: a retrospective open cohort study2025 · 11 citations
  3. 3Impact of GLP-1 Agonists on Male Reproductive Health—A Narrative Review2023 · 29 citations
  4. 4GLP-1 receptor agonists for weight loss for perimenopausal and postmenopausal women: current evidence2025 · 6 citations
  5. 5Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?2015 · 255 citations